SCHEMBL24964681

SCHEMBL24964681

c1cc(-c2ccc3ccccc3c2)cc(N(c2ccc3c(c2)oc2ccccc23)c2ccccc2-c2ccc3c(c2)oc2ccccc23)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HCRTR1 O43613 1/20 0.39
▸ ALOX5 P09917 1/20 0.35
▸ PRKDC P78527 2/20 0.33
▸ HSD17B1 P14061 2/20 0.33
▸ HSD17B2 P37059 2/20 0.33
▸ AHR P35869 2/20 0.33
▸ CYP1A1 P04798 2/20 0.33
▸ CYP1B1 Q16678 2/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ CASP3 P42574 1/20 0.32
▸ SENP7 Q9BQF6 1/20 0.32
▸ SENP6 Q9GZR1 1/20 0.32
▸ GSTP1 P09211 1/20 0.32
▸ MMP12 P39900 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23233324 0.99 HCRTR1 (0.38) HCRTR1ALOX5PRKDCHSD17B1HSD17B2
SCHEMBL23233330 0.99 HCRTR1 (0.38) HCRTR1ALOX5PRKDCHSD17B1HSD17B2
SCHEMBL23233336 0.98 HCRTR1 (0.37) HCRTR1ALOX5PRKDCHSD17B1HSD17B2
SCHEMBL23233104 0.97 HCRTR1 (0.38) HCRTR1ALOX5PRKDCHSD17B1HSD17B2
SCHEMBL23233673 0.96 HCRTR1 (0.38) HCRTR1ALOX5PRKDCHSD17B1HSD17B2
SCHEMBL24964115 0.96 HCRTR1 (0.38) HCRTR1ALOX5PRKDCHSD17B1HSD17B2
SCHEMBL23233211 0.96 HCRTR1 (0.38) HCRTR1ALOX5PRKDCHSD17B1HSD17B2
SCHEMBL23233678 0.96 HCRTR1 (0.38) HCRTR1ALOX5PRKDCHSD17B1HSD17B2
SCHEMBL24919815 0.96 HCRTR1 (0.37) HCRTR1ALOX5HSD17B1HSD17B2AHR
SCHEMBL23233170 0.96 HCRTR1 (0.39) HCRTR1ALOX5PRKDCHSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026162-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026162-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE L1CAM, LEF1, MLX HCRTR1 3134/4885ALOX5 1391/4885PRKDC 4878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback